Search this site

Explore pediatric diffuse gliomas with The Neurosurgical Case Room (TNCR), including molecular classification, clinical presentation, imaging, diagnosis and principles of management. Pediatric Diffuse Gliomas | A Master Class Pediatric Low-Grade Gliomas | Part 1 Part 1 of the Pediatric Low-Grade Gliomas series focuses on distinguishing pediatric-type diffuse low-grade gliomas from adult diffuse gliomas, including cases in adolescent and teenage patients, where diagnostic overlap is common. The discussion centers on pediatric-type diffuse astrocytomas, particularly MYB- and MYBL1-altered tumors, highlighting their biologic behavior, radiologic characteristics, and how they differ from adult-type diffuse gliomas despite similar imaging appearances. Pediatric Low-Grade Gliomas | Part 2 Part 2 of the Pediatric Diffuse Low-Grade Gliomas series focuses on angiocentric glioma and other long-term epilepsy-associated tumors (LEATs), with an emphasis on their clinical behavior, radiologic features, and surgical implications. The discussion explores why certain pediatric diffuse low-grade gliomas present predominantly with epilepsy, how angiocentric glioma fits within the spectrum of pediatric-type diffuse gliomas, and how these tumors differ biologically and prognostically from adult diffuse gliomas. Pediatric Low-Grade Gliomas | Part 3 Part 3 of the Pediatric Diffuse Low-Grade Gliomas series focuses on PLNTY (Polymorphous Low-Grade Neuroepithelial Tumor of the Young) and related epilepsy-associated pediatric tumors, with an emphasis on their epileptogenic behavior and surgical implications. The discussion explores why certain pediatric low-grade tumors present primarily with seizures, how PLNTY fits within the spectrum of pediatric-type diffuse gliomas and LEATs, and how these tumors differ from both adult diffuse gliomas and other epilepsy-associated lesions. Pediatric Diffuse Gliomas | MAPK Altered & DMG This session in the Pediatric Diffuse Gliomas series focuses on MAPK pathway–altered gliomas and diffuse midline gliomas (DMG), highlighting their biologic behavior, molecular underpinnings, and clinical implications in pediatric and adolescent patients. The discussion explores how MAPK-altered tumors differ from other pediatric diffuse gliomas, why molecular classification is central to diagnosis and prognosis, and how these tumors may present across a wide age spectrum with variable radiologic appearances. Pediatric High Grade Gliomas | Part 2 This session on Pediatric High-Grade Gliomas focuses on the biologic and clinical distinctions between pediatric and adult high-grade gliomas, emphasizing why pediatric tumors represent a fundamentally different disease entity rather than a younger presentation of adult glioblastoma.

Explore hydrocephalus with The Neurosurgical Case Room (TNCR), including classification, pathophysiology, clinical presentation, diagnosis and principles of shunt and endoscopic management. Hydrocephalus Hydrocephalus is defined as an abnormal accumulation of cerebrospinal fluid (CSF) within the ventricular system of the brain, resulting from obstruction of CSF flow, impairment of CSF absorption, or, rarely, CSF overproduction. The pathophysiology reflects either proximal stagnation of CSF, failure of reabsorption, or mechanical blockage anywhere between the ventricular system and the arachnoid granulations. Q. What is the epidemiology of hydrocephalus? Hydrocephalus affects approximately 1–1.5% of the general population. Congenital hydrocephalus has an incidence of 0.9–1.8 per 1000 births, with an overall reported range from 0.2–3.5 per 1000. It may be detected antenatally, at birth, or in the early months of life. Hydrocephalus occurs across all age groups, with congenital and infantile forms being the most common early-life presentations, whereas normal-pressure hydrocephalus predominates in older adults. Q. How do you classify hydrocephalus? Hydrocephalus can be classified broadly into functional, etiologic, pressure-based, and morphologic categories. A. Functional Classification: Obstructive (non-communicating) hydrocephalus: CSF flow is blocked within the ventricular system before reaching the arachnoid granulations. Ventricular enlargement occurs proximal to the obstruction. Communicating (non-obstructive) hydrocephalus: Ventricular pathways remain patent, but CSF absorption at the arachnoid villi is impaired. CSF overproduction: Rare; occurs mainly in choroid plexus tumors. Absorption is usually partially compensatory unless flow is obstructed. B. Etiologic Classification Congenital Acquired Post-infectious Post-hemorrhagic Neoplastic Vascular Genetic (e.g., X-linked hydrocephalus) C. Pressure-Based Classification Normal-pressure hydrocephalus Hydrocephalus ex vacuo Long-standing overt ventriculomegaly in adults (LOVA) D. Morphologic (Radiologic) Classification Univentricular enlargement (e.g. entrapped 4th ventricle) Biventricular enlargement (e.g. obstruction at foramen of monro) Triventricular hydrocephalus (e.g. aqueductal stenosis) Communicating ventriculomegaly (secondary to IVH or meningitis, e.t.c.) Entrapped fourth ventricle Q. What are the etiologies of hydrocephalus? A. Congenital Causes Chiari II malformation with myelomeningocele Chiari I malformation Primary congenital aqueductal stenosis Secondary aqueductal gliosis from intrauterine events Dandy–Walker malformation (atresia of Magendie and Luschka) X-linked hydrocephalus (L1CAM mutation) Encephaloceles Other developmental anomalies affecting posterior fossa CSF pathways or foraminal patency B. Acquired Causes Infectious: bacterial meningitis, TB meningitis, cysticercosis Hemorrhagic: intraventricular hemorrhage (IVH), subarachnoid hemorrhage (SAH) Neoplastic: tumors obstructing CSF flow (colloid cyst, medulloblastoma, ependymoma, suprasellar tumors) Postoperative: especially after posterior fossa tumor excision or intraventricular surgery Traumatic: post-traumatic SAH or IVH; scarring of subarachnoid pathways Neurosarcoidosis: granulomatous obstruction of CSF pathways C. Vascular Causes Arteriovenous malformations Vein of Galen aneurysmal malformation (VGAM) D. Functional/Physiological Causes Constitutional or benign ventriculomegaly Arrested or compensated hydrocephalus (non-progressive) Q. What are the special forms of hydrocephalus? Special variants include: Hydrocephalus ex vacuo LOVA (long-standing overt ventriculomegaly in adults) External hydrocephalus (benign external hydrocephalus) Entrapped fourth ventricle Arrested hydrocephalus Triventricular hydrocephalus Normal-pressure hydrocephalus Q. What are the clinical features of hydrocephalus in older children and adults? Older children and adults typically present with signs attributable to increased intracranial pressure and disruption of periventricular white matter tracts. Headache Nausea and vomiting Papilledema Impaired concentration and cognitive slowing Gait instability Parinaud’s syndrome from tectal pressure Sixth nerve palsy from elevated ICP Personality changes or irritability Urinary incontinence (late) Blurred vision and visual field defects from chronic papilledema Slow ventricular enlargement may present subtly, with cognitive and gait changes preceding overt ICP symptoms. Q. What are the clinical features of hydrocephalus in infants and young children? Symptoms include: Irritability Excessive crying Poor head control Feeding difficulties Vomiting Failure to thrive Developmental delay Signs include: Progressive macrocephaly with OFC crossing percentiles Bulging or tense anterior fontanelle Prominent scalp veins from reversed venous flow Frontal bossing McEwan’s sign: cracked-pot percussion note Setting sun sign: downward deviation of eyes from pressure on suprapineal recess Hyperreflexia Irregular respirations or apneic spells Sutural diastasis in chronic cases Q. How do you measure OFC and what findings suggest hydrocephalus? Technique: Place a non-stretchable measuring tape over the supraorbital ridge anteriorly and around the most prominent point of the occiput posteriorly. Ensure the tape is snug and hair is flattened. Repeat twice; if measurements differ by more than 2 mm, take a third and average the closest two. Abnormal Findings: OFC growth exceeding 1.25 cm per week OFC above 2 SD for age Head circumference rising across percentile curves Persistent macrocephaly relative to overall growth pattern OFC out of proportion to facial/cranial growth Q. What are the radiologic features of hydrocephalus? The radiologic features can be divided into: A. Acute Hydrocephalus: Reflects sudden obstruction or acute failure of CSF resorption. 1. Temporal horn enlargement ≥ 2 mm Earliest and most sensitive sign. Normally TH is barely visible. Criteria for acute hydrocephalus: TH ≥ 2 mm and fissures/sulci not visible OR TH ≥ 2 mm + FH/ID > 0.5 (not Evans index) 2. Ballooning of frontal horns: “Mickey Mouse” ventricles 3. Widening of the third ventricle: Should normally be slit-like 4. Periventricular low density on CT: Represents transependymal interstitial edema due to stasis of flow around ventricles 5. Periventricular T2 hyperintensity on MRI: Represents CSF stasis rather than actual CSF diffusion through ependyma. 6. Obstructive patterns: Dilated ventricles proximal to the block, for e.g. colloid cyst can cause biventricular enlargement 7. Loss of cortical sulci and cisterns (effacement): Due to acute rise in ICP 8. Upward bowing of corpus callosum from ventricular expansion B. Chronic Hydrocephalus – Radiologic Features Chronic hydrocephalus produces characteristic long-standing changes due to sustained ventricular expansion and cranial remodeling: Beaten copper or beaten silver cranium on skull radiographs Third ventricular downward ballooning into the sella Erosion or empty sella from chronic pressure Temporal horns less prominent than in acute states Macrocrania (>98th percentile OFC) Corpus callosum thinning and upward bowing Widened sutures, delayed closure of fontanelles (infants) Cortical mantle thinning from longstanding ventricular expansion Smooth, rounded ventricular contours Often lack of acute transependymal edema Q. What is the Evans Index and how is it interpreted? Evans Index is the ratio of the maximal frontal horn width divided by the maximal biparietal diameter on the same axial CT or MRI slice. Evans Index >0.3 is considered indicating hydrocephalus. Evans Index <0.3 is usually normal (0.25 is considered a grey zone). Q. What are the limitations of the Evans Index? Evans Index is widely used but has several important limitations: The measurement varies with axial slice angle. Maximal biparietal diameter may not lie on the same slice as maximal frontal horn width. Underestimates pediatric hydrocephalus because occipital horns often enlarge more than frontal horns. Variability in the ratio may exceed actual structural differences. Thus, Evans Index alone should never be used as a sole diagnostic criterion. Q. What is McEwan’s sign? McEwan’s sign is a cracked-pot percussion sound produced when tapping the skull of an infant (mostly at anterior fontanelle) with marked hydrocephalus. It is caused by: Separation of sutures Thinning of cranial bones Increased resonance due to enlarged ventricles It is a classic sign of chronic infantile hydrocephalus. Q. What is external hydrocephalus, and how do you differentiate it from true hydrocephalus? External hydrocephalus, also known as benign external hydrocephalus (BESS), is a condition in which CSF accumulates in the subarachnoid spaces, predominantly over the frontal and frontoparietal convexities, due to delayed maturation of arachnoid villi. It is not obstructive or communicating hydrocephalus, and the ventricles maintain normal or only mildly increased diameter. Pathophysiology: Arachnoid granulations are immature in early infancy. CSF production is normal but absorption is temporarily reduced, thus CSF preferentially expands subarachnoid spaces instead of ventricles. As arachnoid villi mature (by 18–24 months), spaces normalize. Clinical Features: Occurs between 3 and 18 months of age. Macrocephaly with OFC typically above the 97th percentile. Development is normal or near normal. No symptoms of raised intracranial pressure. Positive family history of macrocephaly in some cases. Radiologic Features Enlarged frontal subarachnoid spaces, symmetrical. Interhemispheric fissure widened. Ventricles normal or minimally enlarged, not disproportionate. Cortical mantle thickness normal, which is a major point of differentiation. Cortical vein sign: visible cortical veins crossing the widened subarachnoid spaces, helping differentiate from subdural effusion. Differentiation from True Hydrocephalus External hydrocephalus: Subarachnoid enlargement > ventricular enlargement Normal cortex thickness No sulcal effacement Normal intracranial pressure No transependymal edema Stable OFC growth pattern Resolves spontaneously True hydrocephalus: Ventricular dilation > subarachnoid space dilation Sulcal effacement Periventricular edema Signs of raised ICP Progressive symptoms Requires CSF diversion Course and Prognosis Peaks around 6–12 months Resolves spontaneously by age 2 No long-term neurological deficit expected Management: Observation only Serial OFC and developmental monitoring No role for surgical intervention Imaging only if symptoms change Q. What is arrested hydrocephalus? Arrested hydrocephalus refers to a non-progressive, compensated form of ventriculomegaly in which CSF dynamics reach a steady state. The ventricles are enlarged, but CSF pressure is stable, and the patient has no clinical or radiologic evidence of progression. Pathophysiology: Initial hydrocephalus (congenital, post-infectious, post-hemorrhagic) occurs. CSF absorption pathways partially or completely recover. Ventricular enlargement remains but does not progress. Brain adapts via decreased CSF production, enhanced alternative absorption, and tissue compliance adjustments. Clinical Features: Asymptomatic or minimally symptomatic Normal OFC trajectory in infants No vomiting, irritability, papilledema, or headache Mild developmental delays may persist from initial insult, but no ongoing decline No gait instability or cognitive worsening in older children Radiologic Features Stable ventricular size on sequential CT/MRI No transependymal edema Normal periventricular signal Stable corpus callosum morphology No progressive skull changes In infants: fontanelle and sutures may have adapted and remain static Diagnosis: Requires three components. Clinical stability Radiological stability on serial imaging Absence of raised ICP features Triggers for Reactivation Even stable hydrocephalus can “reactivate”: Meningitis Trauma (sometimes even mild) New hemorrhage Pubertal brain growth Sudden changes in CSF absorption Management: Observation only if fully compensated Serial OFC in infants Neurological and developmental monitoring Imaging every 6–12 months initially Intervention only if reactivation occurs Treatment of Reactivation: ETV if obstructive pattern develops VP shunt if communicating or absorption failure recurs Arrested hydrocephalus should never be shunted unless clearly decompensating, as unnecessary shunting may precipitate subdural hematomas and overdrainage-related complications. Q. What is an entrapped fourth ventricle? Entrapped fourth ventricle is a condition where the fourth ventricle becomes isolated due to obstruction of both its inlet (aqueduct) and outlets (foramina of Magendie and Luschka), leading to progressive dilation of the fourth ventricle and compression of the brainstem and cerebellum. Pathophysiology: Two simultaneous blocks: 1. Aqueductal obstruction: Prevents CSF flow from third to fourth ventricle. Often secondary to gliosis, hemorrhage, or infection. 2. Outlet obstruction Scarring of Magendie/Luschka caused by meningitis, arachnoiditis, or postoperative scarring. CSF continues to be produced by the choroid plexus inside the fourth ventricle, causing a closed compartment with progressive dilation. Etiology: Post-intraventricular hemorrhage Post-meningitic or TB meningitis scarring Postoperative scarring after posterior fossa surgery Aqueductal gliosis Arachnoiditis VP shunting of supratentorial ventricles, leading to collapse above and pressure buildup below Clinical Features: Symptoms are due to brainstem and cerebellar compression: Ataxia and truncal imbalance Dysarthria and dysphagia Horizontal or vertical gaze palsies Nystagmus Irritability or lethargy in infants Respiratory irregularity or apneic spells New neurological deficits after VP shunt insertion (classic presentation) Head circumference may be normal if supratentorial ventricles are decompressed by a shunt Radiological Features: Isolated dilation of the fourth ventricle Supratentorial ventricles normal or small (post-shunting) Fourth ventricle ballooned posteriorly and inferiorly Brainstem flattened and compressed anteriorly Vermis displaced posteriorly Sagittal MRI best demonstrates outlet and aqueductal obstruction No transependymal edema unless chronic Management Options: 1. Endoscopic Aqueductoplasty Removes glial scar tissue from aqueduct. Balloon dilation performed after perforation. Useful when aqueduct obstruction is the primary problem. 2. Aqueductal Stenting Prevents restenosis of newly opened aqueduct. Required in cases of thick gliosis or scarring. Provides long-lasting patency. 3. Fourth Ventricular Shunting Fourth ventriculoperitoneal shunt Fourth ventriculopleural shunt Indicated when outlet obstruction is absolute or endoscopy is not feasible. Access via midline suboccipital route or transforaminal approach. 4. Endoscopic Third Ventriculostomy (ETV) Useful only if aqueduct is obstructed but outlets are patent after surgical restoration. Provides shunt-free diversion of CSF through the third ventricular floor. 5. Posterior Fossa Surgery: Rarely used and reserved for dense arachnoiditis not amenable to endoscopy or shunting. Follow-up: MRI to confirm reduction in fourth ventricular size Neurological monitoring Shunt surveillance if implanted Q. What is X-linked hydrocephalus? X-linked hydrocephalus is a genetic, congenital, severe obstructive hydrocephalus caused by L1CAM gene mutations on the X chromosome. It is inherited in an X-linked recessive pattern, primarily affecting males. Genetic Basis L1CAM encodes an adhesion molecule critical for neuron migration and axon pathfinding. Mutations lead to: Defective neuronal migration Abnormal axonal guidance Midline structural abnormalities Aqueductal stenosis development Structural Abnormalities: Aqueductal stenosis (congenital or acquired from gliosis) Corpus callosum agenesis or hypoplasia Hydrocephalus with massive ventriculomegaly Corticospinal tract malformations Optic nerve hypoplasia in some cases Periventricular heterotopias may occur Clinical Features: Severe hydrocephalus detected antenatally or at birth Macrocephaly Adducted thumbs (classic hallmark of L1 syndrome) Spasticity Developmental delay Seizures may occur Feeding difficulties Variable cognitive impairment depending on structural severity Radiologic Features: Marked triventricular obstructive hydrocephalus Narrowed or absent aqueduct Enlarged lateral and third ventricles Thin cortical mantle if severe Corpus callosum agenesis or hypoplasia Midbrain structural deformities Possible periventricular leukomalacia from chronic stretch Diagnosis: MRI brain Genetic testing confirming L1CAM mutation Family history analysis Management: 1. Ventriculoperitoneal (VP) Shunt: Mainstay of treatment. Required early in life to prevent brain injury 2. ETV: Often has low success because of: Concomitant cisternal abnormalities Poor subarachnoid compliance Complex aqueductal malformations 3. Supportive Management: Physiotherapy for spasticity, seizure management, and developmental therapies Prognosis: Depends on severity of structural abnormalities, timing of intervention, and presence of associated neurological deficits. Q. What are the complications of untreated hydrocephalus? Neurological Complications: Developmental delay Cognitive impairment Learning difficulties Behavioral deterioration Motor dysfunction (spasticity, hemiparesis, gait abnormalities) Visual impairment due to chronic papilledema Seizures Structural Complications Severe macrocephaly (infants) Skull deformities Cortical thinning and permanent loss of cortical mantle Herniation syndromes in acute obstructive hydrocephalus Systemic Complications: Feeding difficulties Respiratory instability Apneic spells End-stage: cardiorespiratory arrest Untreated hydrocephalus leads to permanent brain injury and is fatal. Q. How do you manage hydrocephalus? A. Temporizing Measures External Ventricular Drain (EVD): Immediate CSF diversion in acute obstructive hydrocephalus (IVH, SAH, tumors, postoperative). Used to stabilize ICP before definitive management. B. Definitive Surgical Procedures 1. Ventriculoperitoneal (VP) Shunt Most common definitive treatment Indications: communicating hydrocephalus, post-infectious hydrocephalus, post-hemorrhagic hydrocephalus, failed ETV, NPH Programmable valves used to reduce overdrainage risks 2. Endoscopic Third Ventriculostomy (ETV) Now taken as First-line for obstructive hydrocephalus Indications: congenital aqueductal stenosis, triventricular obstruction, Chiari-related hydrocephalus Avoids shunt dependence Success dependent on age, etiology, cisternal anatomy 3. ETV with Choroid Plexus Cauterization (ETVCPC) Effective in infants Increases ETV success by reducing CSF production Especially beneficial in spina bifida and complex obstructive etiologies 4. Fourth Ventricular Shunting Indicated for entrapped fourth ventricle Options: VP or VPL shunts with catheter positioned into the fourth ventricle 5. Lumboperitoneal Shunt Used in communicating hydrocephalus with small ventricles Useful in NPH when ventricles are not dilated enough for ventricular catheter placement C. Principles of Management Treat underlying cause (e.g., tumor, infection) Avoid rapid decompression after SAH/IVH to prevent rebleeding Ensure sterile technique to prevent shunt infections Careful valve selection and postoperative monitoring D. Postoperative Follow-up Shunt patency assessment Serial imaging Monitoring for overdrainage (subdural hematoma), underdrainage, infection Neurodevelopmental assessment in children Regular ETV success evaluation (ETVSS considerations)

Explore colloid cysts with The Neurosurgical Case Room (TNCR), including clinical presentation, imaging, hydrocephalus, surgical indications and principles of operative management. Colloid Cyst A colloid cyst is a benign, epithelium-lined lesion arising almost always in the anterosuperior third ventricle at the level of the foramen of Monro. It consists of a smooth-walled spherical cavity filled with a gelatinous, protein-rich material whose viscosity varies from thin fluid to thick, wax-like content. Although histologically benign and slow-growing, a colloid cyst can produce life-threatening obstructive hydrocephalus by acutely blocking CSF flow through one or both foramina of Monro. Q. What anatomical relationships define the behavior of colloid cysts? Colloid cysts arise at the junction of the roof and anterior wall of the third ventricle, usually attached to the inferior layer of the septum pellucidum near the foramen of Monro. They sit between the fornices laterally and superiorly, and the anterior commissure and hypothalamus inferiorly. Even small cysts can obstruct CSF flow due to the narrow diameter of the foramen. Enlargement displaces the fornices laterally and upward, which explains memory disturbances in some patients. Their proximity to the thalamostriate and septal veins creates operative challenges, as venous injury risks infarction or postoperative cognitive deficits. Q. How does the position of a colloid cyst lead to acute neurological deterioration, sudden collapse, or sudden death? Because the cyst lies directly at the foramen of Monro, it can act as a mobile ball-valve that shifts with head position, gravity, or CSF pulsations. Abrupt occlusion of one or both foramina leads to rapid ventricular enlargement, severe intracranial hypertension, and acute cerebral edema. This mechanism explains classic postural or intermittent headaches that worsen when bending forward or lying flat. In severe cases, abrupt total blockage prevents compensatory CSF absorption, resulting in rapid neurological decline, coma, or sudden death. Q. What embryologic theories explain the origin of colloid cysts? The cysts are believed to originate from endodermal or neuroepithelial derivatives. The most widely accepted theory suggests they arise from primitive endodermally derived neuroepithelium within the anterior tela choroidea. Some evidence supports an origin from respiratory-type epithelium, given their columnar, sometimes ciliated lining. Their anatomic restriction to the anterosuperior third ventricle supports a developmental origin tied to early invagination and folding of the primitive neural tube roof. Q. What is the epidemiology of colloid cysts? Colloid cysts account for approximately 0.5–2 percent of all intracranial tumors and about 15–20 percent of intraventricular lesions. They most commonly present in adults between the ages of 20 and 50, though they may be discovered incidentally across age groups. There is no strong sex predilection. Their slow growth and subtle symptoms often delay diagnosis until obstructive hydrocephalus becomes clinically apparent. Q. What is the typical histopathology of a colloid cyst? Histologically, the cyst wall is composed of a fibrous capsule lined by a single layer of cuboidal or columnar epithelium, sometimes ciliated. The cyst contents consist of a gelatinous mixture of cholesterol, mucopolysaccharides, proteinaceous material, and desquamated epithelial debris. The viscosity varies widely and has implications for both endoscopic and microsurgical evacuation. Despite their benign nature, the cyst wall may adhere densely to the fornices or choroid vessels, influencing surgical risk. Q. What clinical symptoms do colloid cysts produce? Symptoms reflect intermittent or progressive obstruction of the foramen of Monro. Patients commonly report episodic headaches worsened by postural change, reflecting transient CSF blockage. Nausea, vomiting, blurred vision, and diplopia may occur as intracranial pressure rises. Memory impairment or executive dysfunction results from forniceal compression. Gait disturbance may develop in chronic hydrocephalus. In acute cases, rapid neurologic decline, reduced consciousness, or sudden collapse may occur due to abrupt ventricular obstruction. Q. How do colloid cysts appear on CT imaging? Most colloid cysts are hyperdense on CT due to their protein-rich contents, though density varies with composition. Calcification is rare. CT is excellent for showing ventriculomegaly and acute hydrocephalus. The cyst appears as a sharply circumscribed spherical lesion at the foramen of Monro, often displacing the septum pellucidum or lateral ventricular walls. Q. How do colloid cysts appear on MRI? MRI signal varies with the cyst’s protein and cholesterol content. They are typically hyperintense on T1 and iso- or hypointense on T2, though signal patterns are variable. They may appear homogeneous or heterogeneous internally. Post-contrast enhancement is minimal or absent. The key MRI features include forniceal bowing, obstruction of CSF flow at the foramen, and symmetric or asymmetric ventricular enlargement. Flow voids or turbulence may be seen near the foramen in cases of partial obstruction. Q. What radiologic features suggest elevated surgical complexity? Features include large cyst size causing extreme fornix stretching, asymmetric ventricular dilatation suggesting unilateral foramen obstruction, adherence of the cyst to choroidal vessels, or proximity to the anterior septal and thalamostriate veins. Thick, heterogeneous cyst contents imply high viscosity, making endoscopic aspiration difficult. Q. What conditions must be considered in the differential diagnosis of a third ventricular mass at the foramen of Monro? Differential diagnoses include intraventricular neurocytoma, subependymoma, central neurocytoma extending inferiorly, ependymal cyst, epidermoid cyst, arachnoid cyst, craniopharyngioma (intracranial extension), choroid plexus papilloma, lipoma, and small hypothalamic gliomas. Key distinguishing features for colloid cyst are its characteristic anterior third ventricular location, spherical morphology, well-defined wall, typical CT hyperdensity, and variable T1/T2 signal without strong enhancement. (CENTRAL MS) Q. Why do some colloid cysts remain asymptomatic despite obstructive potential? Cysts with soft, low-viscosity contents may deform or partially collapse with CSF pulsations, reducing obstruction. Others are positioned slightly above or behind the foramen, allowing CSF to pass around them. Slow ventricular enlargement permits compensation before symptoms arise. However, even asymptomatic cysts can suddenly obstruct, underscoring the importance of surveillance in selected cases. Q. What is the Recursive Partitioning Analysis classification for colloid cysts, and how does it assist in counselling patients? The Recursive Partitioning Analysis system stratifies patients according to age, cyst size, and ventricular size in order to predict the likelihood of symptomatic progression and to guide management. Class I includes lesions that measure ten millimeters or less in patients of any age who have normal ventricular size. These patients carry a low risk of symptomatic deterioration and can be followed with serial clinical and imaging surveillance. Class II includes patients older than fifty years with cysts that measure ten millimeters or less and who have ventriculomegaly. This group has intermediate risk, and observation is acceptable provided they remain asymptomatic. Class III includes cysts larger than ten millimeters or any cyst associated with ventriculomegaly in patients fifty years of age or younger. This group carries a high risk of obstructive episodes, and surgical removal is recommended. The classification helps in counselling by providing a quantitative understanding of long term risk, allowing patients to make informed decisions about the benefits of prophylactic surgery when they fall into higher risk categories. Q. What are the Beaumont risk zones for colloid cysts, and how do these zones modify management decisions in borderline cases? The Beaumont system divides colloid cysts into Zone I, Zone II, and Zone III according to their position along the anterior to posterior axis of the third ventricle in order to predict the likelihood and severity of CSF obstruction. Zone I lesions occupy the anterior third ventricular region near the foramen of Monro and are considered high risk because even small cysts in this location can abruptly obstruct bilateral outflow with minimal movement, producing rapid clinical deterioration. Zone III lesions lie in the posterior third ventricle and are also dangerous because posterior displacement can compromise the aqueduct and create sudden triventricular hydrocephalus with a steep rise in intracranial pressure. Zone II lesions lie in the middle third ventricle and tend to behave in a more indolent manner because their position is less likely to cause abrupt obstruction, which allows more conservative monitoring in selected cases. When managing borderline patients, cysts in Zones I and III generally prompt earlier operative consideration even if they are small or produce minimal symptoms, because their anatomic position carries a higher intrinsic risk of acute obstructive episodes. Q. What is the surgical classification of colloid cysts based on their relationship to the foramen of Monro, and how do they differ in terms of operative access and surgical risk? This classification divides colloid cysts into four types according to how their position affects safe entry into the third ventricle and the protection of nearby structures. The Open Monro type is characterized by an enlarged and easily accessible foramen that permits a straightforward transforaminal endoscopic route with minimal manipulation of surrounding anatomy. The Closed Monro type involves a narrow or slit-like foramen that obstructs direct entry, which makes surgery more challenging because controlled enlargement or an alternate transchoroidal path is needed to avoid traction on the fornix. The Retroforaminal type describes a cyst that lies behind an open foramen, requiring an extended transchoroidal or angled approach to reach the posterior third ventricular region safely. The Interforniceal type places the cyst between the two fornices and displaces them laterally, which creates a high risk of memory impairment because dissection in this corridor threatens the integrity of forniceal pathways. Q. What clinical, radiologic, and patient factors differentiate high-risk from low-risk asymptomatic colloid cysts? Risk stratification in asymptomatic patients evaluates four key domains: Cyst Size & Morphology: Cysts >7-10 mm are high-risk; cysts <7mm without mass effect are low-risk. Signal Characteristics & Viscosity: FLAIR or T2 hypointensity indicates hyperdense, protein-rich, highly viscous contents that are more rigid, prone to abrupt obstruction, and difficult to aspirate endoscopically. Homogeneous, non-viscous cysts on MRI carry lower risk. Ventricular Dynamics: Ventriculomegaly or early bowing of the septum pellucidum indicates impaired CSF clearance, whereas normal ventricular size without outflow obstruction indicates low risk. Patient Age & Symptoms: Patients <65 years are at higher risk due to lower intracranial compliance (causing rapid ICP spikes during transient blockage) and a longer lifetime horizon for potential growth. Transient, subtle, or positional headaches further signify intermittent obstruction. Q. What are the absolute and relative indications for surgical intervention in colloid cysts? Absolute indications include symptomatic presentation (positional headaches, cognitive decline, gait disturbance, papilledema, or intracranial hypertension), radiologic obstructive hydrocephalus, forniceal displacement, progressive enlargement on serial imaging, or acute neurological decline. Relative indications apply to asymptomatic patients meeting high-risk criteria (diameter >10 mm, FLAIR hyperintensity/viscosity, ventriculomegaly, age <65, or strong patient preference for definitive cure to avoid long-term risks). Q. What factors guide the selection between endoscopic, interhemispheric transcallosal, and transcortical transventricular approaches? Surgical selection depends on four primary parameters: Ventricular Size: Enlarged ventricles favor endoscopic or transcortical routes; narrow or slit-like ventricles favor the midline transcallosal approach. Cyst Viscosity & Wall Adherence: Soft or moderately viscous cysts favor endoscopic decompression. Highly viscous/firm contents, thick walls, or tight adherence to choroid vessels and fornices favor microsurgical resection (transcallosal or transcortical) for complete capsule removal. Venous & Anatomical Constraints: Unfavorable venous anatomy or retroforaminal/interforniceal trajectories favor microsurgical approaches to protect the septal, thalamostriate, and internal cerebral veins. Surgeon Experience & Minimal Invasiveness: Endoscopy preserves cortical tissue and accelerates recovery, whereas microsurgery offers superior bimanual dissection and binocular visualization. Q. How will you perform an interhemispheric transcallosal approach for a colloid cyst? I will position the patient supine with the head in a neutral position and slightly flexed to bring the interhemispheric fissure horizontal. I will make a midline incision and fashion a parasagittal craniotomy that crosses the midline to expose the superior sagittal sinus and adjacent dura. I will open the dura parallel to the sinus and gently dissect the interhemispheric fissure using the natural separation between the medial frontal lobes. I will preserve bridging veins by working in the avascular plane whenever possible. Once I reach the corpus callosum, I will make a small callosotomy of approximately one to two centimeters to enter the lateral ventricle. I will visualise the foramen of Monro and identify the cyst at the roof of the third ventricle. I will first decompress the cyst by aspirating its contents to reduce tension. I will then dissect the capsule away from the fornix, internal cerebral veins, and choroid plexus using meticulous microsurgical technique. I will remove the entire capsule when safely possible, achieving hemostasis before closing the ventricle and dura and replacing the bone flap. Q. What are the advantages of the interhemispheric transcallosal approach? This approach provides a midline route that avoids cortical injury, gives excellent binocular visualization of the foramen of Monro and the third ventricular roof, and allows controlled manipulation around the fornices and deep venous structures. It is particularly advantageous when the ventricles are enlarged and when the cyst contents are firm or highly viscous. The midline trajectory allows safe dissection of adherent capsule and reduces the risk of intraventricular bleeding from veins that may not be well visualized through an endoscope. Q. What are the limitations of the interhemispheric transcallosal approach? Limitations include the need to work between the medial frontal lobes, which increases the risk of venous injury if bridging veins obstruct the operative corridor. A callosotomy is required, which can rarely cause disconnection symptoms if extended too far. Narrow or slit ventricles can make ventricular entry difficult and may increase forniceal manipulation. Access to large posteriorly extending cysts may also be restricted. Q. How will you perform a transcortical transventricular microsurgical approach for a colloid cyst? I will position the patient supine with the head in a neutral position. Through a small frontal cortical incision placed anterior to the motor cortex and above the caudate head, I will enter the lateral ventricle under neuronavigation guidance. I will widen the working corridor using gentle retraction only as needed. After identifying the foramen of Monro, I will visualise the cyst and decompress it by aspirating its contents. I will then dissect the cyst wall from the fornix, septal veins, and choroidal attachment. If the capsule is firmly adherent, I will peel it in a circumferential fashion while respecting venous structures. After complete removal, I will irrigate the ventricle, ensure hemostasis, and close the cortex and dura in layers. Q. What are the advantages of the transcortical approach? This approach provides direct access to the cyst and allows wide visualization of the foramen of Monro. It is well suited to patients with enlarged ventricles and large cysts. Instrument maneuverability is excellent, and the route offers the ability to remove cysts with thick walls and high viscosity. It is also relatively fast and does not require callosal opening. Q. What are the limitations of the transcortical approach? The primary limitation is the potential for cortical injury that can cause postoperative seizures or cognitive changes, particularly in patients with small ventricles. Excessive retraction may damage white matter tracts or the caudate head. Venous bleeding within the ventricle can cloud the field, and care must be taken to avoid the thalamostriate and septal veins. Q. How will you perform an endoscopic resection of a colloid cyst? I will position the patient supine with the head slightly elevated. I will create a small frontal burr hole, typically at Kocher’s point, and place a sheath into the lateral ventricle under navigation guidance. Through a rigid or flexible endoscope, I will visualize the foramen of Monro and the cyst. I will aspirate the cyst contents using a suction catheter or a dedicated aspiration instrument to decompress the lesion. Once the cyst has collapsed, I will dissect the capsule from the fornix and venous structures under endoscopic guidance. I will remove capsule fragments using graspers or bipolar forceps. Irrigation will be used to maintain a clear field. If the capsule is densely adherent and unsafe to remove completely, I will perform a safe subtotal resection. After confirming hemostasis, I will withdraw the endoscope and close the wound. Q. What are the advantages of the endoscopic approach? Endoscopy is minimally invasive, preserves cortical tissue, and allows rapid recovery. Visualization of the foramen of Monro, septal veins, and the fornix is excellent with modern optics. Cyst aspiration decompresses the lesion quickly, and the maneuverability of endoscopic tools reduces tissue trauma. It is well suited for soft or moderately viscous cysts and for patients with enlarged ventricles. Q. What are the limitations of the endoscopic approach? A single working channel limits bimanual technique, making dissection of thick or adherent capsule more difficult. Very viscous contents may not aspirate easily. Bleeding can obscure vision quickly. Complete capsule removal may not be possible, particularly when the cyst is adherent to the choroid plexus or fornical surfaces. Narrow ventricles reduce maneuverability and increase the risk of forniceal stretching. Q. What is the role of CSF diversion in the management of colloid cysts? CSF diversion is required in emergencies when acute hydrocephalus threatens life or neurological function. An external ventricular drain stabilizes the patient but does not address the underlying obstructive lesion. Permanent shunting is rarely indicated because it leaves the cyst in place and permits future obstruction. Temporary drainage is often used as a bridge to definitive surgical removal of the cyst once the patient is stable. Q. What technical strategies protect the fornices, deep venous structures, and surrounding brain during colloid cyst surgery? Critical intraoperative risk mitigation relies on: Internal Decompression First: Puncturing and aspirating cyst contents prior to capsule mobilization collapses the lesion, relieving tension on the bowed fornices and preventing stretch injury. Forniceal Protection: Dissection must strictly follow natural arachnoid planes without upward or lateral traction. Blind passage of instruments behind the cyst is avoided. Venous Preservation: The septal, thalamostriate, and internal cerebral veins must be clearly identified. Direct coagulation near their junctions must be avoided to prevent venous infarction of the caudate, thalamus, or fornix. Managing Viscous Contents: Viscous material is managed by fenestration, warm irrigation, probe morcellation, or larger-bore suction. If endoscopic aspiration fails, conversion to bimanual microsurgery is indicated. Safe Capsule Excision: Circumferential mobilization is performed only along clear planes. Adherent capsule remnants on critical venous or forniceal structures are left as safe subtotal resections rather than risking neurological deficit. Q. What immediate postoperative complications can occur after colloid cyst removal? Acute hydrocephalus may occur if postoperative edema or blood obstructs the foramen of Monro. Memory deficits may appear if the fornices were stretched or contused during dissection. Postoperative seizures can follow transcortical approaches. Transient confusion or lethargy may result from changes in CSF dynamics. In rare cases, intracerebral hemorrhage or infarction may result from venous injury. Close monitoring in the early postoperative period allows timely intervention. Q. What delayed complications should be considered after surgery? Delayed complications include subdural hygroma, chronic headaches due to altered CSF flow, seizures, and persistent short term memory impairment. Scar formation near the foramen of Monro can cause delayed hydrocephalus. Rarely, cyst recurrence may occur if part of the capsule remained. Endoscopic approaches may carry a small risk of incomplete removal that becomes symptomatic months or years later. Q. Why are memory disturbances a well known postoperative concern? The fornices transmit memory pathways between the hippocampus and the thalamus. Even minimal traction or contusion can produce measurable deficits, especially short term memory loss. The risk increases when the cyst is large and the fornices are thinned or bowed preoperatively. Although many patients improve over time, some degree of subtle impairment may persist, which is why protecting the fornices is a central principle in all approaches. Q. How do you manage postoperative hydrocephalus in patients who have undergone colloid cyst surgery? I begin with neuroimaging to identify whether obstruction results from blood, edema, or residual cyst wall. If acute hydrocephalus is present, I place an external ventricular drain to stabilize the patient. Most cases improve as swelling subsides, allowing the drain to be removed in a controlled fashion. Permanent shunting is rarely required, but it may be necessary if the foramen remains narrowed or if adhesions develop that prevent normal CSF circulation. Q. What factors predict cyst recurrence after surgical removal? Recurrence occurs when part of the capsule remains attached to the choroid plexus or to the roof of the third ventricle. Endoscopic approaches have a slightly higher recurrence risk because capsule removal is more difficult through a single working channel. Thick walled cysts or cysts with firm adhesion to surrounding structures are more likely to leave microscopic remnants. Complete capsule removal when safe to do so significantly reduces recurrence. Q. How do you manage recurrence of a colloid cyst? Management depends on the size of the recurrence and the presence of symptoms. Small, asymptomatic recurrences may be monitored. Symptomatic or enlarging cysts require repeat surgery, which may be endoscopic or microsurgical depending on anatomy and adhesion from prior procedures. If the cyst recurs because of incomplete capsule removal, a definitive approach that allows safe excision of the residual capsule should be chosen. Q. What is the overall prognosis after successful colloid cyst removal? The prognosis is excellent in most patients. When the cyst is fully removed and the fornices are preserved, patients typically experience resolution of headaches and stabilization or improvement of cognitive symptoms. The risk of recurrence is very low after complete capsule removal. Long term neurological outcomes are closely tied to protection of the fornices and avoidance of venous injury. Q. What is your follow up protocol after resection of a colloid cyst? I obtain a postoperative MRI within the first week to confirm complete removal and to evaluate ventricular size. Follow up imaging is repeated at six months and one year. Annual imaging for several years can be considered in cases where capsule removal was incomplete or if the initial surgery was endoscopic. Clinical follow up includes assessment of memory, executive function, gait, and symptoms of raised intracranial pressure. Long term surveillance is indicated to monitor for late recurrence or delayed hydrocephalus.

Explore spinal dysraphism with The Neurosurgical Case Room (TNCR), including embryology, classification, clinical presentation, imaging, associated anomalies and principles of neurosurgical management. Spinal Dysraphism Q. What do you mean by spinal dysraphism? Spinal dysraphism refers to a spectrum of congenital defects arising from abnormal closure, development, or separation of the neural tube and its surrounding mesenchymal structures. It includes open dysraphism (neural tissue exposed due to failed primary neurulation, e.g., myelomeningocele, myeloschisis) and closed dysraphism (skin-covered lesions resulting from disordered neurulation or mesenchymal differentiation, e.g., lipomyelomeningocele, dermal sinus tract, diastematomyelia). Q. How do you classify spinal dysraphism? Spinal dysraphism is broadly classified into: Open spinal dysraphism (not covered with skin): These result from failed primary neurulation and include: Myelomeningocele Myeloschisis Closed spinal dysraphism (skin-covered): These arise from defective disjunction or disordered mesenchymal development and include: Lipomyelomeningocele Lipomyelocele Dermal sinus tract Neurenteric cyst Diastematomyelia (split cord malformation) Fatty filum/Thick filum Terminal myelocystocele Complex dysraphic syndromes: Currarino triad OEIS complex Caudal regression syndromes Q. How does normal neurulation occur? Neurulation proceeds in two phases: Primary neurulation (third to fourth week): Neural plate folds and fuses to form the neural tube from cervical to upper sacral levels. This process requires coordinated bending, elevation, fusion, and separation of neural ectoderm from non-neural ectoderm. Secondary neurulation (caudal cell mass): Mesenchymal cells condense, canalize, and fuse with the distal neural tube to form the conus and filum terminale. Normal neurulation ends with dysjunction, the separation of neural ectoderm from surface ectoderm, allowing mesenchymal elements to migrate and form vertebral tissues. Q. What are the embryological mechanisms leading to spinal dysraphism? The embryological defects include: Failure of neural tube closure causes open dysraphism such as myelomeningocele or myeloschisis. Premature dysjunction causes mesenchymal invasion into neural folds and leads to lipomyelomeningocele. Failure of dysjunction causes a persistent tract connecting skin and neural tube (dermal sinus). Failure of secondary neurulation causes terminal myelocystocele, caudal regression, tight filum. Midline mesenchymal cleavage anomalies cause diastematomyelia (split cord conditions). Persistent neurenteric canal or endodermal misplacement causes neurenteric cysts. Abnormal notochord formation or splitting causes associated vertebral segmentation defects. The type of dysraphism depends on the timing and level of neurulation failure. Q. What are the pathological differences between open and closed dysraphism? In open dysraphism, neural tissue is externally exposed. The neural placode is continuous with skin edges and lacks meningeal or skin covering. These lesions inevitably involve Chiari II malformation, hydrocephalus, and brainstem abnormalities. In closed dysraphism, the defect is covered by skin and neural elements are contained within the spinal canal. These lesions are more variable; some symptomatic at birth but others present later due to tethering, dermal sinus infection, or inclusion tumors. Q. What is the epidemiology of spinal dysraphism? The global incidence is approximately 1–3 per 1000 live births, with higher rates reported in regions with nutritional deficiencies, including parts of Asia. Myelomeningocele is the most common form. Females are more commonly affected in open dysraphism. Q. What are the major risk factors for spinal dysraphism? Important risk factors include: Maternal folic acid deficiency (most significant modifiable risk factor) Maternal diabetes Hyperthermia during early pregnancy Teratogenic drugs (especially valproate and carbamazepine) Genetic predisposition and consanguinity Intrauterine infections and environmental toxins Adequate folate supplementation reduces the risk by nearly 70%. Q. How does spinal dysraphism present clinically? Presentation depends on subtype. Open dysraphism presents at birth with an exposed neural placode. Motor deficits, sensory loss, and bladder dysfunction are present from birth. Closed dysraphism may be detected by cutaneous markers such as: Hairy tuft Dermal pit or sinus Hemangioma Subcutaneous lipoma Skin tag Asymmetric gluteal cleft Neurological symptoms include: Foot deformities Progressive scoliosis Back pain Lower limb weakness Sensory loss Urological presentation includes neurogenic bladder, urgency, retention, and recurrent UTIs. Dermal sinus tract may present with meningitis or dermoid abscess. Split cord malformation may present with scoliosis, foot deformity, or tethered cord. Q. Which associated anomalies are commonly seen with spinal dysraphism? Chiari II malformation (universal in open dysraphism) Hydrocephalus Syringomyelia Orthopedic deformities (clubfoot, hip dislocation) Neurogenic bladder and bowel dysfunction Vertebral anomalies (hemivertebra, butterfly vertebra) Presacral masses in Currarino syndrome Q. How do you investigate a child with suspected spinal dysraphism? MRI spine is the investigation of choice; it identifies neural placode, fat infiltration, split cord anomalies, dermal sinus tracts, and tethering. MRI brain to assess Chiari II and hydrocephalus in open dysraphism. Ultrasound spine for neonates with skin markers (before ossification). CT spine for bony anomalies such as diastematomyelia spur. Urodynamic studies in all dysraphism patients at baseline. Renal ultrasound for hydronephrosis due to neurogenic bladder. Q. What are the general principles of managing spinal dysraphism? Management is tailored to subtype but general rules include: Open dysraphism requires urgent surgical closure within 24–48 hours to reduce infection risk and protect neural tissue. Hydrocephalus evaluation and treatment (VP shunt or ETV) is integral. Closed dysraphism is managed based on symptoms or high-risk features: Progressive motor or bladder symptoms Dermal sinus tract (absolute indication due to meningitis risk) Lipomyelomeningocele with tethering Split cord malformation with spur Multidisciplinary approach with neurosurgery, urology, orthopedics, rehabilitation. Long-term follow-up for re-tethering, scoliosis, and urological decline. Q. What are the long-term complications of spinal dysraphism? Progressive tethered cord due to growth Re-tethering after surgery Hydrocephalus requiring shunt revisions Inclusion tumors (dermoid/epidermoid) Orthopedic deformities Chronic urological dysfunction leading to renal damage Chronic pain and gait abnormalities Q. What is the prognosis? Prognosis depends on the subtype and timing of intervention. Open dysraphism has lifelong neurological and urological morbidity, although early repair improves outcomes. Closed dysraphism has a more favorable prognosis if detected early and treated before neurological decline. Regular monitoring for re-tethering and bladder deterioration is essential. Q. What is the Currarino triad? Currarino triad is a congenital caudal dysraphism defined by the classic triad of anorectal malformation, hemisacrum (sacral defect), and a presacral mass such as an anterior meningocele, teratoma, or enteric cyst, resulting from abnormal development of the caudal eminence and notochord. Q. What is the OEIS complex? The OEIS complex is a severe midline developmental disorder characterized by Omphalocele, Exstrophy of the cloaca, Imperforate anus, and Spinal defects, representing one of the most severe forms of caudal dysraphism. Q. What is caudal regression syndrome? Caudal regression syndrome is a spectrum of secondary neurulation defects involving variable degrees of sacral agenesis, lumbar vertebral anomalies, and spinal cord dysgenesis, commonly associated with maternal diabetes and presenting with lower-limb, urological, and anorectal abnormalities.

Meet TNCR’s global neurosurgery representatives connecting local communities across countries and supporting collaboration, participation and open-access neurosurgical education. Points of Connection TNCR Representatives are neurosurgeons and trainees who serve as points of connection between The Neurosurgical Case Room and their local neurosurgical communities. They help extend TNCR’s educational reach, encourage participation and collaboration, and connect colleagues with our open-access learning initiatives. - Neurosurgery Without Borders Country Representatives Pakistan Dr. Burhan ul Haq MBBS, MRCS, FCPS NEUROSURGERY Senior Registrar Neurosurgery, Mayo Hospital Lahore Pakistan Dr. Iqra Yasin MBBS, MRCS Final Year Resident, National Hospital Lahore Germany Dr. Hatice Büşra Cukaz MD Neurosurgery Consultant Neurosurgeon, Neurovascular/Endovascular Fellow Hyōgo College of Medicine Hospital, Japan Jordan Dr. Fayez Radi Obeid MD, FRCS Fellowship in Neurosurgery & Skullbase Surgery Consultant Neurosurgeon, Ibn Haitham Hospital, Amman, Jordan Malaysia Dr. Lalithambigai Gannison MBBS, BMS Trainee in Neurosurgery MInistry of Health , Malaysia Palestine Dr. Mohammed Jomaa Asfa Consultant Neurosurgeon, European Gaza Hospital, Gaza Dr. Tawasul Ahmad MBBS, MRCS, MSc. Molecular Medicine, MD Neurosurgery SMSB Consultant Neurosurgeon, ELmak Nimir university hospital Sudan Dr. Md. Yousuf Ahmed Emon MBBS Neurosurgery Resident Dhaka Medical College Hospital, Dhaka Bangladesh Sudan INDIA Dr. Naaga Vishnu Shankar MBBS, MS (General Surgery), MCh (Neurosurgery) Assistant professor Department of Neurosurgery Tirunelveli Medical College, Tirunelveli, Tamil Nadu, India Egypt Dr. Suhail Maged Amer MBBCh Neurosurgery Resident, Al-Sahil Teaching Hospital, Egypt China Dr. Assi Richmond MBBS Neurosurgery Resident, Xiangya Hospital, Changsha City, Hunan Province Mexico Dr. Bernardo Ramos Fraga MD Resident in Endovascular Neurosurgery, Hospital de Especialidades, Centro Médico Nacional La Raza, IMSS ALGERIA Dr. Larabi Ihsene MD Neurosurgery Resident CHU Mustapha Pacha, Algeria Liberia Dr. Siaffa M. Sando MD, MLCPS(Gen.Surgeon), MWACPS Neurosurgery Resident, COSECSA, Muhimbili Orthopedic and Neurosurgery Training Institute, Dar es Salaam, Tanzania Libya Dr. Ayman Aboubakr Emran Hasan Neurosurgery Resident, Ali Omar Askar Neurocenter, Tripoli, Libya Dr. Ibe Bernard Nwoko MBBS, WACS Neurosurgery Resident Lagos University Teaching Hospital(LUTH), Nigeria Nigeria Zimbabwe Dr. Godfrey Rukwava Bsc(Hons), MBChB, PG Dip Endocrinology, MBA Neurosurgery Resident Zimbabwe Association of Neurosurgical Society Comoros Dr. Yasser Mohamed Mouhoudhoiri MD, MSc HUMAN BIOLOGY (ANATOMY) Neurosurgery Resident and Anatomist, CHU de Yopougon, Abidjan, Côte d'Ivoire Kenya Dr. Idris Mohamed Abdullahi Neurosurgery Resident Moi Teaching and Referral Hospital, COSECSA, Kenya Yemen Dr. Moatasem Ali Al-Asali MBBS, MRCS Chief Resident, Al-Basheer hospitals, Amman Somalia Dr. Mohamed Abdi Makaran MBBS, MRCS, Egyptian Board Neurosurgery Neurosurgery Resident Seyidnawy Insurance Hospital, Somalia Ethiopia Dr. Dargie Amare Kahsay MD Neurosurgery Resident,Ayder Comprehensive Specialized Hospital, Mekelle, Tigray, Ethiopia SYRIA Dr. Nayef Soufan German Board-Certified Neurosurgeon, Master’s Degree in Neurosurgery, EuroSpine Diploma Consultant Neurosurgeon Saudi German Hospital – Dubai Peru Dr. Juan Carlos Arapa Diaz Medical Surgeon, UNSA-Peru Master of Science in Physiological Sciences, UFES-Brazil Neurosurgery Resident Carlos Alberto Seguin Escobedo National Hospital, Essalud-Arequipa, Peru Regional Representatives Dr. Bushra Maqsood MBBS, (FCPS Neurosurgery) Jinnah Postgraduate Medical Center, Karachi, Pakistan Pakistan Pakistan Dr. Noorullah MBBS, (FCPS Neurosurgery) TR Neurosurgery, Lady Reading Hospital, Peshawar, Pakistan Pakistan Dr. Jawariya Zia MBBS, (FCPS Neurosurgery) Specialty Registrar, Sir Ganga Ram Hospital, Lahore, Pakistan Pakistan Dr. Nouman Haider MBBS, MRCS, MSPH, CHPE Neurosurgery Resident, Pakistan Institute Of Medical Sciences, Islamabad, Pakistan Dr. Aamir Irshad MBBS, (FCPS Neurosurgery) Trainee Registrar, Ayub Medical Complex, Abbottabad, Pakistan Dr. Shahid Khan MBBS Neurosurgery Resident, MTI – Hayatabad Medical Complex Peshawar, Pakistan Pakistan Pakistan India Dr. Ankit Patel MS, MCh (Neurosurgery) Consultant Neurosurgeon Kiran Multi Super Speciality Hospital Surat, Gujarat, India INDIA Dr. Ajit Kumar MBBS, Dr.N.B Neurosurgery Consultant Neurosurgeon Lisie Hospital, Ernakulam, Kerala, India Dr. Sapan Gandhi MBBS, (Dr.N.B Neurosurgery) Neurosurgery Resident, Sakra World Hospital, Bengaluru, India India INDIA Dr. Obaid Bin Rashid MBBS, MS (General & Minimal Invasive Surgery), (MCH) Neurosurgery Resident, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar Dr. Hussein Al - Harby MBBS, MRCS Neurosurgery Resident, Egyptian Board, Sheikh Zayed Specialized Hospital, Cairo Sudan Dr. Asim Ahmed MBBS, MHPE Neurosurgery Resident, Sudan Medical Specialization Board YEMEN Dr. Lee Wei Lun MD, MS Neurosurgery Consultant Neurosurgeon, Hospital Kuala Lumpur, Malaysia Malaysia

Explore miscellaneous neurosurgery review topics with The Neurosurgical Case Room (TNCR), covering selected clinical concepts and practical topics for neurosurgical residents and trainees. Coming Soon.

Explore clinoidal meningioma with The Neurosurgical Case Room (TNCR), including relevant anatomy, clinical presentation, imaging, surgical approaches and principles of operative management. Clinoidal Meningioma A clinoidal meningioma is a meningioma arising from the dura of the anterior clinoid process and its immediate periclinoidal region, situated at the junction of the optic canal, carotid cistern, and cavernous sinus roof. Operatively, it is defined by its early and intimate relationship with the optic nerve, optic canal, and clinoid segment of the internal carotid artery, often before significant lateral sphenoid wing involvement develops. Q. How is a clinoidal meningioma different from a medial sphenoid wing meningioma, and why does this distinction matter surgically? Clinoidal meningiomas originate directly from the anterior clinoid and involve the optic canal and carotid artery early, whereas medial sphenoid wing meningiomas arise from the medial sphenoid ridge and secondarily extend toward the optic canal and clinoid. Surgically, clinoidal meningiomas more frequently lack a safe arachnoid plane over the carotid artery, require optic canal decompression as a core step, and carry higher risk to vision and vascular structures compared with medial sphenoid wing tumors. Q. What is the typical clinical presentation of clinoidal meningioma, and why do symptoms appear early? Symptoms appear early because the tumor develops in a confined skull base space adjacent to the optic nerve and carotid artery. Progressive unilateral visual loss is the most common presentation. Headache is frequent, while seizures are uncommon unless there is significant frontal extension. Neurological deficits are often disproportionate to tumor size due to early optic nerve compromise. Q. How does visual loss present in clinoidal meningioma, and what patterns are characteristic? Visual loss is typically unilateral, slowly progressive, and painless. It may begin with reduced visual acuity, color desaturation, or central scotoma. Visual field defects reflect prechiasmatic optic nerve compression rather than chiasmal involvement, and recovery depends on duration and severity of compression. Q. What fundoscopic and neuro-ophthalmic findings are expected, and what do they signify anatomically? Optic atrophy is common and reflects chronic optic nerve compression within the optic canal. Disc edema may be seen in earlier stages or with raised intracranial pressure. Relative afferent pupillary defect indicates asymmetric optic nerve involvement. These findings localize pathology to the prechiasmatic optic nerve and canal. Q. What cranial nerve deficits may occur, and what do they indicate about tumor extension? Oculomotor nerve palsy, diplopia, or ptosis suggest cavernous sinus roof involvement. Trigeminal sensory changes may occur with lateral extension. These findings indicate tumor spread beyond the pure clinoidal region and increase surgical complexity. Q. When and why do endocrine symptoms occur in clinoidal meningioma? Endocrine symptoms are uncommon but may occur when the tumor compromises the superior hypophyseal arteries or extends toward the pituitary stalk. Such findings suggest suprasellar extension and increase the need for cautious vascular preservation. Q. What are the critical regional anatomical structures involved in clinoidal meningioma surgery? The anterior clinoid process, optic canal, falciform ligament, distal dural ring, clinoid and supraclinoid segments of the internal carotid artery, ophthalmic artery, superior hypophyseal arteries, cavernous sinus roof, optic chiasm, A1 and M1 segments, and their perforators. Q. Why is the anterior clinoid process central to the behavior and management of these tumors? The anterior clinoid forms the bony core of the tumor origin. Hyperostosis and dural attachment here restrict exposure, compress the optic nerve, and tether the carotid artery. Its removal expands surgical corridors and enables safe optic canal decompression. Q. What is the surgical significance of the optic canal and falciform ligament? The optic canal is frequently involved early, causing visual loss. The falciform ligament compresses the optic nerve superiorly and must be opened to fully decompress the nerve and allow mobilization without traction. Q. What is the distal dural ring, and why does it matter during carotid dissection? The distal dural ring marks the transition of the internal carotid artery from cavernous to intradural. Tumor adherence at this point predicts loss of an arachnoid plane and increases risk of carotid injury. Q. Why is the clinoid segment of the internal carotid artery uniquely vulnerable? It lies fixed between bony and dural structures with limited mobility. Tumor encasement here often lacks a protective arachnoid plane, making sharp dissection hazardous. Q. Why are the ophthalmic artery and superior hypophyseal arteries critical? They supply the optic nerve, chiasm, and pituitary stalk. Injury results in irreversible visual loss or endocrine dysfunction, making their identification and preservation mandatory. Q. How does cavernous sinus roof involvement alter surgical goals? True invasion mandates a conservative strategy with planned residual tumor, as aggressive resection risks cranial nerve and carotid injury. Q. What is the Al-Mefty classification of clinoidal meningiomas? Type I tumors arise from the lower clinoid region and encase the carotid artery early, usually without an arachnoid plane. Type II tumors arise from the superior clinoid and grow lateral to the carotid artery with a preserved arachnoid plane. Type III tumors arise near the optic foramen and primarily involve the optic canal. Type I tumors carry the highest vascular risk and often require subtotal resection. Type II tumors are most amenable to gross total resection. Type III tumors require meticulous optic canal work but usually allow safe carotid preservation. Q. What investigations are needed for a patient with suspected clinoidal meningioma? I will start with a focused clinical and functional assessment because the operation is judged by visual outcome and vascular safety rather than by extent of resection alone. I will document baseline visual acuity in each eye, color vision, pupillary responses including relative afferent pupillary defect, formal perimetry for visual fields, and fundus examination to record optic disc edema or optic atrophy. I will obtain a baseline cranial nerve examination with special attention to ocular motility and ptosis to screen for cavernous sinus roof involvement. I will assess for cognitive or frontal lobe symptoms if the tumor has anterior extension. I will screen endocrine function selectively, focusing on morning cortisol and thyroid function if symptoms suggest hypothalamic or stalk region involvement, or if imaging shows suprasellar extension, because endocrine issues are not typical but become relevant when the superior hypophyseal complex is threatened. I will also establish a preoperative neurological baseline for counseling and postoperative comparison, and I will coordinate neuro-ophthalmology documentation because small changes postoperatively carry major functional consequences. Q. What imaging is needed and what must you specifically look for? MRI with contrast is the defining investigation. On MRI I will determine whether the tumor originates at the anterior clinoid and periclinoidal dura, assess the tumor–optic nerve relationship, and identify optic canal involvement. I will specifically look for loss of the cerebrospinal fluid cleft at the optic nerve and carotid cistern because this suggests loss of an arachnoid plane. I will assess the degree and length of internal carotid artery encasement, any luminal narrowing, and whether the tumor extends into the cavernous sinus roof. I will evaluate the relationship to the optic chiasm, A1 segment, M1 segment, and perforators, and I will assess brain edema and pial blood supply features that increase operative bleeding and cortex vulnerability. I will obtain CT of the skull base to assess hyperostosis of the anterior clinoid process, optic canal roof, and sphenoid ridge, because drilling strategy and extent of clinoidectomy depend on this. I will evaluate calcification and bony anatomy to plan safe canal unroofing and to anticipate how much skull base work is required to decompress the optic nerve fully. Q. How does imaging help differentiate clinoidal from medial sphenoid wing meningioma? Primary clinoidal origin, clinoidal hyperostosis, early canal involvement, and concentric carotid encasement favor clinoidal meningioma, whereas lateral ridge origin with secondary canal extension favors medial sphenoid wing tumors. Q. When do you need vascular imaging and what does it change in your plan? I will obtain vascular imaging when MRI suggests significant carotid encasement, luminal narrowing, or when the interface between the tumor and carotid artery appears unsafe. CTA or MRA helps define the caliber of the carotid artery and its relationship to the tumor, but if surgical risk is high or if vessel narrowing is present, I will prefer formal angiographic characterization to understand collateral flow and to plan for vascular rescue if needed. The practical purpose is not to prove a diagnosis but to anticipate whether the operation is likely to require planned subtotal resection, whether proximal control and vascular preparedness must be heightened, and whether the tumor is behaving more like a high-risk Al-Mefty type I lesion with no safe plane. Q. What are the management goals in clinoidal meningioma? The primary goal is preservation or improvement of vision while avoiding internal carotid artery injury and perforator infarction. Tumor control is achieved by maximal safe resection, and if safe planes do not exist at the carotid artery or cavernous sinus, planned subtotal resection is preferred over aggressive dissection. The quality measure in this operation is the functional outcome, and that it is acceptable and often correct to leave tumor on the carotid artery or within the cavernous sinus to prevent catastrophic morbidity. Long-term control is then achieved through surveillance and adjuvant radiosurgery or fractionated radiotherapy depending on residual size, location, and grade. Q. What surgical approaches are possible for clinoidal meningioma and what are the approach selection rules? The standard workhorse approach is a pterional craniotomy with wide Sylvian fissure opening, because it provides direct access to the optic nerve, carotid cistern, proximal Sylvian corridor, and the anterior clinoid region. A cranio-orbital or orbitozygomatic extension is chosen when increased skull base working angles are needed, particularly for large tumors, significant superior extension, or when extensive drilling of the clinoid and optic canal is required and a flatter trajectory will reduce brain retraction. A lateral supraorbital approach can be used in selected smaller lesions with minimal lateral extension where a minimally invasive corridor still allows safe cisternal access and optic canal work, but it is not favored when carotid encasement is significant because the corridor is less forgiving for vascular control and drilling. The practical rule is that the approach must allow early CSF release, controlled skull base drilling, and safe management of the optic canal and carotid interface without traction. Q. How do you incorporate Al-Mefty classification into management planning? I will use Al-Mefty classification as a predictor of whether an arachnoid plane exists at the carotid artery and therefore whether gross total resection is realistic. In Al-Mefty type I tumors, carotid encasement occurs early and a safe arachnoid plane is often absent, so I will plan for deliberate subtotal resection, leaving adherent tumor on the carotid artery and treating residual disease with radiosurgery if appropriate. In type II tumors, a plane is more commonly preserved and gross total resection may be achievable with careful microsurgical technique. In type III tumors, optic canal involvement dominates, and decompression and canal clearance become the key steps while carotid risk may be less severe. Procedure: Pterional or Cranio-Orbital Approach With Optic Canal Decompression and Selective Anterior Clinoidectomy Q. How will you perform surgical excision of a clinoidal meningioma using a pterional or cranio-orbital approach? I will position the patient supine with the head fixed, elevated, mildly extended, and rotated contralaterally to align the Sylvian fissure horizontally and facilitate gravity-assisted frontal lobe relaxation. I will perform a frontotemporal skin incision and reflect the scalp and temporalis muscle to expose the pterion and sphenoid ridge. I will carry out a pterional craniotomy, extending to a cranio-orbital exposure when additional skull base working angles are required to minimize brain retraction and allow controlled drilling. I will begin with the extradural phase. I will elevate the frontal dura extradurally from the anterior skull base and sphenoid wing. I will identify and divide the meningo-orbital band to mobilize the dura propria of the cavernous sinus laterally. I will unroof the superior orbital fissure by opening its lateral wall, exposing the anterior clinoid process in the extradural plane. Using a high-speed drill with a diamond burr under continuous irrigation, I will drill the anterior clinoid process circumferentially. As I approach the clinoidal segment of the internal carotid artery, I will intentionally thin the bone to an egg-shell thickness rather than drilling it completely. I will then remove the remaining thin bone carefully using fine rongeurs and microcurettes to avoid thermal or mechanical injury to the artery. I will proceed to unroof the optic canal extradurally by drilling the bone overlying the optic nerve to achieve early optic nerve decompression. I will then drill and remove the optic strut, the bony pillar connecting the anterior clinoid process to the body of the sphenoid, which frees the clinoid completely. I will detach and remove the anterior clinoid process in a controlled fashion, thereby expanding the parasellar surgical corridor and exposing the clinoidal internal carotid artery, distal dural ring, and optic nerve before tumor manipulation. After completing the extradural skull base work, I will open the dura in a curvilinear fashion based toward the skull base. I will open the Sylvian fissure widely under microscopic visualization, starting distally and progressing proximally to release cerebrospinal fluid and achieve brain relaxation. I will identify the optic nerve and internal carotid artery early and establish orientation to the tumor. I will coagulate and divide dural feeders at the tumor base to achieve early devascularization. I will internally debulk the tumor in a piecemeal fashion to reduce mass effect before attempting capsule mobilization. I will decompress the optic nerve further by opening the falciform ligament and removing any intracanalicular tumor, using sharp dissection and gentle suction while preserving the pial blood supply of the optic nerve. I will then dissect the tumor from the optic nerve and surrounding cisternal structures along preserved arachnoid planes. I will address the tumor–internal carotid artery interface next. If a clear arachnoid plane exists, I will perform meticulous sharp dissection circumferentially, allowing the capsule to separate without traction. If no safe plane exists and the tumor is densely adherent to the carotid artery or its perforators, I will deliberately leave a thin layer of tumor on the vessel rather than risk vascular injury. I will not attempt aggressive resection of tumor extending into the cavernous sinus and will accept a planned residual in this region. I will complete hemostasis with careful inspection of the optic canal, carotid cistern, and tumor bed, avoiding packing that could compress the optic nerve. I will close the dura in a watertight manner, reconstruct skull base drilling defects when necessary, replace the bone flap, and close the wound in layers. Q. What are the complications of clinoidal meningioma surgery? Perioperative complications These include optic nerve injury from traction, thermal injury, or ischemia; internal carotid artery injury during clinoidectomy or tumor dissection; injury to ophthalmic or superior hypophyseal arteries leading to visual loss or endocrine dysfunction; cavernous sinus bleeding; perforator injury from A1 or M1 segments; excessive blood loss due to early tumor devascularization failure; cranial nerve III palsy from cavernous sinus roof manipulation; and air embolism during skull base drilling. Early postoperative complications These include worsening or new visual loss due to optic nerve edema, ischemia, residual canal compression, or hematoma; ischemic stroke from perforator injury, carotid thrombosis, or vasospasm; intracranial hematoma; seizures; CSF leak due to skull base drilling and inadequate dural closure; electrolyte disturbances and endocrine dysfunction when suprasellar structures are affected; cranial nerve palsies; and wound-related complications. Delayed postoperative complications These include persistent visual deficit; delayed ischemic events; tumor recurrence or progression of planned residual; radiation-related complications after adjuvant therapy; chronic cranial nerve deficits; late-onset seizures; and CSF leak or pseudomeningocele. Q. What is the general postoperative management after clinoidal meningioma surgery? I will manage the patient in a high-dependency or intensive care setting with close neurological and visual monitoring. I will document immediate postoperative visual acuity, pupillary responses, and visual fields and repeat these serially to detect early deterioration. I will maintain stable blood pressure and euvolemia to optimize optic nerve and perforator perfusion, avoiding hypotension and excessive hypertension. I will administer corticosteroids to control optic nerve and cerebral edema and taper them based on clinical response. I will monitor fluid balance, electrolytes, and endocrine parameters when suprasellar manipulation has occurred. I will obtain early postoperative imaging if there is any neurological or visual deterioration, or routinely within the first 24 to 48 hours to establish a baseline. I will initiate seizure prophylaxis selectively and manage pain while avoiding excessive sedation that could mask neurological changes. Q. How will you manage postoperative visual deterioration? I will treat postoperative visual deterioration as an emergency. I will immediately assess visual acuity, pupillary reflexes, and fundoscopic findings. I will obtain urgent imaging to identify reversible causes such as residual optic canal compression, hematoma, excessive packing, or infarction. I will escalate corticosteroid therapy to reduce optic nerve edema. If imaging shows compressive pathology or inadequate canal decompression, I will proceed to early surgical re-exploration to decompress the optic nerve and canal. If ischemic optic neuropathy is suspected without compressive cause, I will optimize perfusion, avoid hypotension, and continue supportive management, recognizing that recovery may be limited. Q. How will you manage an internal carotid artery–related complication postoperatively? If there is suspicion of carotid thrombosis, dissection, or pseudoaneurysm, I will obtain urgent vascular imaging. I will coordinate early with endovascular services. Management may include antiplatelet therapy, anticoagulation, or endovascular intervention depending on the pathology and bleeding risk. Blood pressure will be tightly controlled to support cerebral perfusion while minimizing hemorrhagic risk. Q. How will you manage postoperative ischemic stroke or perforator infarction? I will confirm the diagnosis with imaging and determine the vascular territory involved. I will optimize cerebral perfusion pressure, manage edema with steroids or osmotherapy when indicated, and provide supportive neurocritical care. Antithrombotic therapy will be considered on a case-by-case basis after weighing hemorrhagic risk. Early rehabilitation planning will be initiated. Q. How will you manage cerebrospinal fluid leak after clinoidal meningioma surgery? I will initially manage CSF leak conservatively with head elevation, wound care, and CSF diversion when appropriate. If the leak persists or is associated with meningitis risk, I will proceed to surgical repair with reinforcement of the skull base defect and watertight dural closure. Q. How will you manage cranial nerve III palsy? I will document the deficit and exclude compressive or ischemic causes on imaging. Most cases are managed conservatively with observation, steroids for edema, and ophthalmologic support, recognizing that recovery may take weeks to months. Q. A patient develops acute visual deterioration six hours after surgery with a fixed dilated pupil. How will you manage this situation? I will treat this as an emergency. I will immediately assess visual function and pupillary responses and obtain urgent imaging to look for hematoma, optic canal compression, or vascular compromise. I will administer high-dose steroids and, if imaging shows a compressive cause or inadequate decompression, I will proceed to immediate surgical re-exploration to decompress the optic nerve and relieve pressure. Q. A patient is neurologically stable but MRI shows a thin residual tumor encasing the internal carotid artery. How will you manage this postoperatively? I will observe the patient clinically and establish this MRI as a postoperative baseline. I will not attempt early reoperation. I will plan close radiologic surveillance and discuss adjuvant radiosurgery or fractionated radiotherapy depending on residual size, growth on follow-up imaging, and proximity to critical structures. Q. On postoperative day two, the patient develops new hemiparesis with imaging showing a small perforator infarct. What is your management strategy? I will manage the patient in a neurocritical care setting, optimize cerebral perfusion, control edema, and avoid hypotension. I will provide supportive care and initiate early rehabilitation. Antithrombotic therapy will be considered cautiously after evaluating hemorrhagic risk and infarct mechanism. Q. What is the role of radiotherapy in the management of clinoidal meningioma? Radiotherapy is used as an adjuvant treatment for residual or recurrent clinoidal meningioma when complete surgical excision is unsafe or not achievable, particularly for tumor adherent to the internal carotid artery, optic apparatus, or extending into the cavernous sinus. It is also indicated for higher-grade tumors where recurrence risk is elevated. Radiotherapy allows durable tumor control while avoiding the morbidity of aggressive reoperation in a high-risk skull base region. Q. Which radiotherapy modalities are used for clinoidal meningioma and how do you choose between them? The main modalities include stereotactic radiosurgery, fractionated stereotactic radiotherapy, and conventional fractionated external beam radiotherapy. Stereotactic radiosurgery is preferred for small, well-defined residual tumors that are at a safe distance from the optic nerve and chiasm. Fractionated stereotactic radiotherapy is chosen when the residual tumor is close to the optic apparatus or internal carotid artery, allowing dose delivery to be spread over multiple fractions to reduce toxicity. Conventional fractionated radiotherapy is reserved for larger residual volumes, recurrent disease, or higher-grade meningiomas where broader coverage is required. Q. What are the typical radiation doses used for WHO grade 1 clinoidal meningioma? For stereotactic radiosurgery, a marginal dose of approximately 12 to 14 Gy is commonly used, provided the optic nerve and chiasm dose constraints can be respected. For fractionated stereotactic or conventional radiotherapy, a total dose of 50 to 54 Gy delivered in daily fractions of 1.8 to 2 Gy is standard. Dose planning prioritizes protection of the optic apparatus and internal carotid artery. Q. What dose constraints are critical when irradiating clinoidal meningiomas? The most critical constraints involve the optic nerve and optic chiasm. For single-fraction radiosurgery, the maximum dose to the optic apparatus should generally not exceed 8 to 10 Gy. For fractionated regimens, cumulative dose to the optic nerves and chiasm is typically kept below 54 Gy. Care is also taken to limit dose to the internal carotid artery to reduce the risk of late radiation-induced vasculopathy. Q. What are the early side effects of radiotherapy for clinoidal meningioma? Early side effects include fatigue, scalp erythema, transient headache, nausea, and temporary worsening of neurological symptoms due to radiation-induced edema. Transient visual symptoms may occur from optic nerve swelling, particularly in tumors close to the optic canal. These effects are usually self-limited and managed with corticosteroids and supportive care. Q. What are the late or delayed side effects of radiotherapy in this region? Late complications include radiation-induced optic neuropathy, which can result in permanent visual loss, radiation necrosis of adjacent brain tissue, and delayed cranial nerve deficits. Vascular complications such as carotid artery stenosis or occlusion may occur years after treatment. There is also a small risk of hypopituitarism when the pituitary stalk or gland receives significant radiation dose. Q. How do you minimize radiotherapy-related complications in clinoidal meningioma? Complications are minimized through careful patient selection, precise target delineation, adherence to strict dose constraints for the optic apparatus and vascular structures, and use of fractionated techniques when tumors are close to critical anatomy. Close collaboration with radiation oncology and long-term follow-up with serial imaging and neuro-ophthalmologic assessment are essential. Q. How does Simpson grading apply to clinoidal meningioma, and why is it less predictive of recurrence in this location? In clinoidal meningioma, achieving a low Simpson grade is frequently limited by adherence of tumor to the internal carotid artery, optic nerve, and cavernous sinus roof. Radical dural excision or coagulation at the clinoid and periclinoidal region is often unsafe. As a result, Simpson grade does not reliably predict recurrence because deliberate residual tumor is commonly left on critical neurovascular structures. Long-term tumor control depends more on biological behavior, residual volume, and appropriate use of adjuvant radiotherapy than on aggressive pursuit of Simpson grade I or II resection. Q. What is the role of preoperative embolization in clinoidal meningioma, and why is it usually avoided? Preoperative embolization is generally avoided in clinoidal meningioma because the tumor’s blood supply frequently arises from small dural branches closely associated with the internal carotid artery, ophthalmic artery, and superior hypophyseal system. Embolization carries a significant risk of ischemic optic neuropathy, retinal ischemia, and cranial nerve injury. Additionally, many clinoidal meningiomas derive pial blood supply, which cannot be safely embolized. The risks usually outweigh the benefits, and intraoperative devascularization under direct vision is preferred. Q. What is the significance of peritumoral brain edema and pial blood supply in clinoidal meningioma? Marked brain edema and evidence of pial blood supply indicate loss of a clean arachnoid plane between the tumor and adjacent brain or vessels. This predicts more difficult dissection, increased bleeding, and higher risk of neurological morbidity. Such features suggest that aggressive resection may be unsafe and that planned subtotal resection with adjuvant radiotherapy may provide better functional outcomes. Q. What factors predict visual recovery after surgery for clinoidal meningioma? Visual recovery is most strongly predicted by shorter duration of visual symptoms, absence of established optic atrophy, and early and complete optic canal decompression. Patients with disc edema rather than optic atrophy have a better chance of improvement. Severe long-standing visual loss and chronic optic atrophy are associated with limited or no recovery despite technically adequate decompression. Q. What is the role of the endoscopic endonasal approach in clinoidal meningioma? The endoscopic endonasal approach has a limited role in clinoidal meningioma because these tumors commonly encase the internal carotid artery laterally and involve the optic canal and clinoid region beyond the midline. Lateral vascular control, management of carotid encasement, and optic canal work are more safely achieved via transcranial approaches. Endonasal surgery may be considered only in highly selected midline lesions without significant lateral extension or carotid involvement. Q. What is the recommended follow-up strategy after surgery and or radiotherapy for clinoidal meningioma? After surgery, an early postoperative MRI is obtained to establish a baseline. In cases of gross total resection, imaging is repeated at regular intervals, typically annually. After subtotal resection or radiotherapy, closer surveillance is required, with imaging at shorter intervals initially to monitor residual tumor stability or progression. Long-term neuro-ophthalmologic follow-up is essential to assess visual function and detect delayed complications. Q. Why must optic canal decompression be performed early rather than late in clinoidal meningioma surgery? Early optic canal decompression relieves pressure on the optic nerve before tumor manipulation, reducing the risk of ischemic or traction-related injury. Decompression after tumor removal exposes an already compromised nerve to edema and vascular insult, increasing the likelihood of postoperative visual deterioration. Early decompression also allows safer mobilization of the optic nerve during tumor dissection. Q. What are the differences between intradural and extradural anterior clinoidectomy, and why is extradural clinoidectomy preferred? Extradural anterior clinoidectomy allows early optic nerve decompression and proximal vascular control before intradural tumor manipulation, while maintaining the protective dural layer over neurovascular structures during drilling. It reduces the risk of thermal and mechanical injury to the optic nerve and internal carotid artery and provides a wider surgical corridor. Intradural clinoidectomy is associated with higher risk because drilling is performed adjacent to exposed neurovascular structures and is therefore less favored in clinoidal meningioma surgery. There is a higher risk of thermal injury to surrounding nerves, along with chemical meningitis due to bone dust within the subarachnoid space. Q. How will you manage an intraoperative internal carotid artery injury during clinoidal meningioma surgery? Once arterial injury is identified, I will immediately stop further dissection. I will call for anesthetic support and ensure normotension or mild permissive hypertension to maintain cerebral perfusion. I will flood the operative field with saline to prevent air embolism. I will apply gentle focal tamponade directly over the injury using a cottonoid or small muscle pledget, avoiding circumferential compression that could occlude the vessel lumen. Temporary proximal control If bleeding is brisk or uncontrolled, I will obtain proximal control of the internal carotid artery. This may be achieved by temporary clipping of the cervical internal carotid artery if exposed, or by proximal intracranial control if anatomy permits. Temporary control is used only to stabilize the situation and should be as brief as possible to limit ischemic risk. Temporary clips should be applied parallel to the vessel axis to avoid intimal injury. I will assess whether the injury is a small puncture or linear tear, a laceration with tissue loss, or a circumferential defect. This determines the repair strategy. Primary repair For small puncture or linear tears, I will perform primary repair using fine nonabsorbable microsutures under high magnification. Sutures will be placed parallel to the long axis of the artery to avoid luminal narrowing. Care will be taken not to incorporate the posterior wall or adjacent perforators. Patch repair If the arterial wall is friable or the defect is larger, I will perform patch angioplasty using autologous material such as temporalis fascia or pericranium. The patch will be sized to restore the arterial contour without causing stenosis. Sutures will be placed meticulously to ensure watertight closure. Use of hemostatic agents Adjunctive use of hemostatic agents may be applied externally to reinforce the repair, but intraluminal packing is avoided because it promotes thrombosis and delayed occlusion. When repair is not feasible If primary or patch repair cannot be safely performed due to extensive arterial damage, I will maintain temporary control and immediately involve endovascular colleagues. Options include covered stent placement or vessel reconstruction. Vessel sacrifice is considered only as a last resort and only after confirming adequate collateral circulation, because it carries a high risk of stroke. Intraoperative monitoring after repair After repair, I will release temporary control and observe the artery for bleeding, narrowing, or discoloration. I will ensure that distal flow is restored and that there is no expanding hematoma. If available, intraoperative Doppler or angiographic assessment may be used to confirm patency. Postoperative management Postoperatively, I will manage the patient in a neurocritical care setting. I will obtain early vascular imaging to confirm arterial patency and exclude pseudoaneurysm formation. Blood pressure will be tightly controlled to balance perfusion with hemorrhagic risk. Antiplatelet or anticoagulation therapy will be considered in consultation with vascular and endovascular teams, based on the type of repair and bleeding risk. Delayed considerations I will maintain a high index of suspicion for delayed pseudoaneurysm, thrombosis, or vasospasm. Surveillance imaging is mandatory because delayed rupture of a pseudoaneurysm can be catastrophic. Long-term follow-up is essential even if immediate repair appears successful.

Explore meningiomas with The Neurosurgical Case Room (TNCR), including classification, molecular features, clinical presentation, imaging, surgical planning and principles of management. Meningiomas Tentorial Meningioma The session focuses on how to understand tentorial meningioma locations, surgical corridors, operative planning, and key anatomical landmarks that guide safe tumor removal. The goal is to make complex skull base anatomy clear, structured, and easy to remember for neurosurgery residents and practicing neurosurgeons. Foramen Magnum Meningioma In this episode of Mefty Made Easy, we simplify the concept of foramen magnum meningiomas, focusing on the key anatomical relationships, tumor classification, and surgical considerations that every neurosurgeon should understand. Using imaging and anatomical concepts, this session explains the location of foramen magnum meningiomas, their relationship to the brainstem, vertebral artery, lower cranial nerves, and the surgical corridors used for safe tumor removal. Transclival Approach & Foramen Magnum Meningioma In this episode of Mefty Made Easy, we explore the transclival approach to foramen magnum meningiomas and its role in skull base surgery. This session explains the endoscopic endonasal corridor to the clivus, the anatomical relationships of the brainstem, vertebral artery, and lower cranial nerves, and how these structures influence surgical planning. Olfactory Groove Meningioma In this episode of Mefty Made Easy, we simplify the concept of olfactory groove meningiomas, focusing on their surgical anatomy, clinical presentation, radiologic features, and operative approaches. These tumors arise from the anterior cranial fossa along the cribriform plate and planum sphenoidale, often presenting with anosmia, frontal lobe symptoms, and visual disturbances. Clinoidal Meningioma & Surgical Anatomy | Part 1 This video focuses on the core anatomical concepts and classification systems essential for understanding clinoidal meningiomas. Complex skull base anatomy is broken down into clear, exam-oriented explanations, with emphasis on the MEFTY classification and its surgical relevance. Clinoidal Meningioma | Part 2 This video builds on foundational anatomy and classification to cover the real-world clinical and operative aspects of clinoidal meningiomas. The topic is simplified into clear, exam-oriented concepts, helping you connect anatomy with surgical decision-making. Sphenoid Wing Meningioma | Part 1 Master Sphenoid Wing Meningioma in this high-yield session from the MEFTY Made Easy Series, designed for neurosurgery residents and exam candidates. This video simplifies the complex skull base anatomy and surgical considerations of sphenoid wing meningiomas into clear, exam-oriented concepts. With a focus on anatomical relationships and operative thinking, this session builds a strong foundation for both viva preparation and clinical application. Sphenoid Wing Meningioma | Part 2 In this video, we simplify the anatomy of sphenoid wing meningioma, focusing on key surgical and anatomical concepts essential for neurosurgery residents and trainees. We cover: Sphenoid wing anatomy and surgical relevance Relationship to critical neurovascular structures Key concepts for operative planning Practical insights for real-world neurosurgical decision-making Parasagittal Meningioma | Part 1 In Part 1 of this Parasagittal Meningioma series, we focus on the critical microsurgical anatomy that determines safe operative planning and execution. This session emphasizes the anatomy and surgical significance of the superior sagittal sinus, cortical draining veins, bridging veins, falx cerebri, and venous collateral pathways. Understanding these structures is essential for selecting the correct approach, minimizing venous injury, and avoiding catastrophic postoperative complications such as venous infarction and brain swelling. Parasagittal Meningioma | Part 2 In Part 2 of this Parasagittal Meningioma series, we focus on the classification, clinical presentation, and radiologic evaluation of parasagittal meningiomas. This session discusses how tumor location along the superior sagittal sinus influences symptoms, venous involvement, surgical complexity, and operative planning. We also review the key MRI and CT findings that help differentiate parasagittal meningiomas from other extra-axial lesions. Surgical Management of Parasagittal Meningioma In this video, we discuss the surgical management of parasagittal meningiomas with a focus on operative planning, venous preservation, and microsurgical strategy. Parasagittal meningiomas present unique challenges because of their relationship with the superior sagittal sinus and cortical draining veins. This session emphasizes how surgical anatomy influences positioning, craniotomy design, dural opening, tumor devascularization, sinus management, and safe resection techniques. Falcine Meningioma Part 1 | Surgical Anatomy, Classification and Venous Relationships In Part 1 of this Falcine Meningioma series, we discuss the essential surgical anatomy, classification, and venous relationships that form the foundation for safe operative planning. Falcine meningiomas present unique microsurgical challenges because of their deep interhemispheric location and close relationship to the falx cerebri, superior sagittal sinus, cortical draining veins, pericallosal arteries, and medial frontal/parietal cortex. Falcine Meningioma Part 2 | Clinical Presentation, Classification, & MRI Findings In Part 2 of this Falcine Meningioma series, we discuss the clinical presentation, radiologic evaluation, classification systems, surgical principles, and important operative adjuncts relevant to falcine meningioma surgery. This session focuses on how tumor location within the falx influences symptoms, venous anatomy, surgical complexity, and operative planning. We also review the conventional classification systems as well as the Das et al. classification and their relevance in surgical decision-making. Falcine Meningioma Surgical Management | Interhemispheric Approach and Microsurgical Strategy In this video, we discuss the surgical management of falcine meningiomas with a focus on interhemispheric microsurgical anatomy, operative strategy, and safe tumor resection principles. Falcine meningiomas are challenging lesions because of their deep location and close relationship to the falx cerebri, superior sagittal sinus, cortical bridging veins, and pericallosal arteries. This session emphasizes how surgical anatomy directly influences positioning, craniotomy planning, venous preservation, tumor devascularization, and operative decision-making. Falcotentorial Meningioma Part 1 | Surgical Anatomy and Deep Venous Relationships & Classification In Part 1 of this Falcotentorial Meningioma series, we discuss the complex surgical anatomy and deep venous relationships that are critical for safe operative planning and microsurgical resection. Falcotentorial meningiomas are rare and technically demanding lesions located at the junction of the falx cerebri and tentorium cerebelli, closely related to the deep venous system, vein of Galen, straight sinus, internal cerebral veins, and pineal region anatomy. This session focuses on understanding the microsurgical anatomy that determines surgical approach selection, venous preservation, operative corridors, and complication avoidance. Falcotentorial Meningioma Part 2 | Presentation, Approaches, Deep Venous Anatomy & Operative Nuances Falcotentorial meningiomas remain among the most technically demanding intracranial tumors because of their deep location and intimate relationship with the vein of Galen complex, straight sinus, internal cerebral veins, basal veins of Rosenthal, and the tentorial incisura. In Part 2 of this Falcotentorial Meningioma series, we focus on the surgical management of these challenging lesions. Through a practical neurosurgical perspective, we discuss operative planning, patient positioning, surgical corridors, deep venous anatomy, tumor devascularization, microsurgical dissection techniques, and strategies for preserving critical venous structures. Occipital Transtentorial Approach Explained | Surgical Anatomy, Indications, Deep Venous System The Occipital Transtentorial Approach (OTA) is one of the most versatile and elegant microsurgical corridors for accessing lesions of the pineal region, posterior third ventricle, falcotentorial junction, tentorial incisura, and deep midline structures. In this episode of The Surgical Blueprint, we simplify the anatomy, indications, surgical planning, patient positioning, tentorial opening, deep venous anatomy, and technical nuances of the occipital transtentorial approach. Sphenoid Wing Meningioma | Part 2 In this video, we simplify the anatomy of sphenoid wing meningioma, focusing on key surgical and anatomical concepts essential for neurosurgery residents and trainees. We cover: Sphenoid wing anatomy and surgical relevance Relationship to critical neurovascular structures Key concepts for operative planning Practical insights for real-world neurosurgical decision-making

Review adult diffuse gliomas with The Neurosurgical Case Room (TNCR) through structured, case-based video sessions covering diagnosis, classification, evaluation and management. Astrocytomas & Oligodendrogliomas Diffuse gliomas represent a spectrum of infiltrative tumors with distinct molecular and clinical behavior. Understanding classification and surgical strategy is key to management. Glioblastoma Part 1 of the Glioblastoma series focuses on diagnostic foundations, including classification, radiologic patterns, common imaging pitfalls, wounded glioma syndrome, and histologic subtypes, discussed through real clinical cases. A major emphasis of this session is understanding why radiology alone can be misleading, how glioblastoma can mimic other pathologies, and how neurosurgeons integrate imaging with clinical reasoning in day-to-day practice. Part 2 of the Glioblastoma series builds on the diagnostic foundations discussed earlier and focuses on prognostic assessment, treatment strategy, and evolving concepts in glioblastoma management, discussed through real clinical cases. Key areas of discussion include radiomics and advanced imaging features, how prognostic information is derived from clinical and radiologic variables, and how these factors influence surgical planning, extent of resection, and adjuvant treatment decisions in routine practice.

Learn about The Neurosurgical Case Room (TNCR), a global, open-access neurosurgical community supporting residents and early-career consultants through structured learning, academic exchange and international collaboration. Excellence, without borders The Neurosurgical Case Room (TNCR) was born in Pakistan from a simple conviction: where a neurosurgeon trains should not determine the quality of education they can access. Across the world, neurosurgical training remains profoundly unequal. Geography, institutional resources, subspecialty exposure, access to mentors, operative volume, travel costs, and logistical limitations can all shape what a trainee gets the opportunity to learn. Yet the patients we treat demand the same depth of understanding, wherever we practice. TNCR exists to help narrow that gap. We are building a curriculum-driven neurosurgical learning ecosystem: one in which complex subjects are broken down systematically, from foundational anatomy and pathophysiology to imaging, decision-making, surgical approaches, operative anatomy, technique, complications, and real-world clinical application. The goal is simple: what you learn should change what you can understand, decide, and do when you encounter the next patient. Our Mission: Building a Neurosurgical Library for the World Our long-term vision is ambitious: to build one of the world's largest structured neurosurgical video libraries, covering neurosurgery not as a collection of disconnected topics, but as a continuously expanding curriculum. A trainee should be able to arrive at TNCR with a subject they need to master and find a logical pathway through it. Over time, we envision TNCR becoming a living repository of neurosurgical knowledge: organized enough to learn from systematically, practical enough to return to before a case, and accessible enough to reach a trainee thousands of kilometres from a major academic centre. OUR COMMUNITY · OUR IMPACT Your Experience Matters Has The Neurosurgical Case Room contributed to your learning, clinical reasoning, or surgical decision-making? Share your experience and help us document its educational impact. Share Your TNCR Experience →

Review Cervical Lateral Mass Screws with concise neurosurgical notes covering anatomy, entry points, trajectories, techniques, complications, and key exam concepts. Cervical Lateral Mass Screw Fixation Q. What are the indications for lateral mass screw fixation? Used primarily for posterior subaxial cervical spine (C3–C7) stabilization in setting of: Degenerative disorders (e.g., spondylotic myelopathy/radiculopathy requiring multi-level laminectomy and fusion). Traumatic instability (e.g., facet fractures, dislocations, ligamentous disruption). Neoplastic or infectious destruction of the subaxial spine requiring posterior reconstructive stabilization. Post-laminectomy kyphosis or structural deformity correction. Q. What are the contraindications? Structural compromise of the lateral mass (e.g., severe comminuted fractures, tumor destruction, active osteomyelitis/discitis). Morphologically small or dysplastic lateral masses (frequently encountered at C7). Anomalous course or medial orientation of the vertebral artery in the transverse foramen (visualized on preoperative CT angiography). Severe osteoporosis where pedicle screws or multi-segmental constructs are required for adequate biomechanical purchase. Q. What is the patient positioning and exposure? Positioning: Prone position on a radiolucent table with skull fixation via a Mayfield pin clamp or rigid foam headrest. Neck positioned in neutral or slight flexion to open the posterior elements. Shoulders taped caudally to allow unobstructed lateral intraoperative fluoroscopy down to C7–T1. Exposure: Midline sagittal skin incision following the avascular subperiosteal plane along the spinous processes and laminae. Dissection extended laterally over the facet capsules to the outer edge of the lateral masses while preserving capsular integrity at non-fused levels. Q. What is the entry point and trajectory? (Magerl Technique baseline) Entry Point: 1 mm medial to the geometric center of the lateral mass (or 1–2 mm superior and medial to the center of the lateral mass). Trajectory: Angle 15–20° cephalad (parallel to the facet joint plane) and 25–30° laterally (aiming toward the anterolateral corner of the lateral mass) to avoid the spinal canal, nerve root, and vertebral artery. Dimensions: Standard hardware utilizes 3.5 mm diameter screws with lengths ranging between 12–16 mm (typically longer at C3–C5, shorter at C7). C7 Variant: Due to a thinner lateral mass and transition to thoracic pedicle anatomy at C7, trajectory requires a steeper lateral angulation or conversion to a C7 pedicle screw. Q. How will you perform the fixation? Pilot Hole Creation: Identify entry point and drill the pilot hole using a 2.5 mm drill bit with a set depth guard (e.g., 12–14 mm) along the predetermined 15-20 cephalad and 30 lateral trajectory. Tactile Sounding & Tapping: Sound the drill tract with a ball-tip probe to confirm an intact cortical perimeter (no ventral or medial breach), followed by gentle tapping if using non-self-tapping screws. Screw Insertion: Insert 3.5 mm polyaxial lateral mass screws maintaining exact trajectory angulation. Construct Assembly: Contour longitudinal rods, seat into polyaxial screw heads, apply cross-link devices if indicated, and perform final tightening under compression or neutral alignment. Q. What are the key precautions during drilling and insertion? Avoid inadequate or zero lateral trajectory to prevent catastrophic vertebral artery injury in the transverse foramen. Avoid neutral or caudal trajectory to prevent exit-zone nerve root injury in the intervertebral foramen. Do not strip or violate the C2–C3 facet capsule or detach muscle attachments from the C2 spinous process to prevent postoperative iatrogenic instability or C2–C3 junctional breakdown. Q. What is the biomechanical reason for a 25–30° lateral trajectory in lateral mass screw fixation, and what are the clinical consequences of violating it? Directing the drill bit 25–30° laterally away from the midline sagittal plane establishes a two-plane safety margin: Transverse Foramen & Vertebral Artery Protection (Safety Corridor): Angles the trajectory away from the medially located transverse foramen and spinal canal, directing the screw tip safely into the solid bone pillar at the anterolateral corner of the lateral mass. Nerve Root Protection (Superior Angle Safeguard): Combining 25–30° lateral angulation with a 15–20° cephalad tilt (parallel to the facet joint plane) directs the screw tip above the exit zone of the spinal nerve root in the intervertebral foramen. Clinical Consequences of Trajectory Violation: Vertebral Artery Laceration: Rapid, high-pressure arterial hemorrhage into the posterior surgical field that is extremely difficult to achieve direct hemostasis on. Thrombosis, Dissection, & Stroke: Pseudoaneurysm formation, vessel wall dissection, or acute thrombosis leading to posterior circulation stroke (brainstem or cerebellar infarction). Venous Plexus Breach & Air Embolism: Inadvertent entry into the rich peri-arterial venous plexus within the transverse foramen, risking excessive venous bleeding, local tamponade, or systemic air embolism. Q. What are the complications of lateral mass screw placement? Neurovascular Injury: Vertebral artery laceration/thrombosis or C3–C8 nerve root impingement/radiculopathy. Facet Joint Violation: Inadvertent drill/screw penetration into adjacent uninvolved superior or inferior facet joints. Hardware Failure: Lateral mass fracture during drilling/tapping, screw pullout/loosening, or rod-screw construct dislodgement (especially at C7). Structural: Dural tear with CSF leakage or post-laminectomy kyphosis secondary to unanchored construct. Q. What are the salvage or bailout options? Roy-Camille Technique: Shift entry point to the true center of the lateral mass with a perpendicular trajectory (0 cephalad, 10 lateral) if the superior facet edge is damaged. Subaxial Pedicle Screws: Convert to cervical or thoracic pedicle screw fixation (especially at C7 or T1) for significantly higher pullout strength. Fixation Extension: Extend hardware fixation one or two levels caudally or cranially into intact lateral masses/pedicles. Supplemental Stabilization: Utilize posterior interspinous/laminar structural wiring or back up with an anterior cervical discectomy/corpectomy and plated fusion. Q. What critical technical nuances help prevent neurovascular injury during subaxial lateral mass screw placement? Obtain baseline fluoroscopic lateral and AP X-rays after final positioning to confirm anatomic alignment before making the skin incision. Palpate and precisely identify key landmarks: C2 spinous process (large bifid anchor), C6/C7 transition (prominent spinous process), and the bony margins of each lateral mass. Maintain strictly midline subperiosteal dissection to reduce venous plexus bleeding and preserve surrounding soft tissues. Insert a small Penfield dissector into the facet joint space as a visual guide to ensure the drill trajectory remains parallel to the joint plane (15-20 cephalad). Maintain a strict minimum of 25-30 lateral trajectory to safeguard the vertebral artery and nerve root. Q. What are the expected outcomes? Lateral mass screw fixation provides strong, multi-segmental rigid posterior stabilization with high clinical success rates and predictable fusion rates (>95%). When performed using strict anatomical landmarks, fluoroscopic guidance, and intraoperative neuromonitoring (MEPs/SSEPs), neurovascular complication rates are exceptionally low.

Explore brainstem neurosurgery with The Neurosurgical Case Room (TNCR), covering surgical anatomy, safe entry zones, brainstem lesions and principles of operative management. Brainstem | Applied Clinical Anatomy & Surgical Approaches Far-lateral Transcondylar Approach The farlateral transcondylar approach is one of the most powerful skull base corridors for lesions at the foramen magnum, ventral brainstem, and lower clivus. In this video, we break it down step by step in a clear, structured, and exam-focused manner. Medulla Oblongata | Rule of 4, Tracts, & Nuclei In this detailed masterclass, we break down the complex anatomy of the brainstem with special focus on the medulla oblongata — integrating topographic anatomy, internal structure, ascending & descending tracts, nuclei, and surgical relevance. Medulla Oblongata | Surgical Anatomy, Nuclei, and Safe Zones The discussion integrates surface landmarks, internal nuclei, long tracts, and clinically relevant safe entry zones, translating complex brainstem anatomy into real-world surgical decision-making. Surgical Approaches to Medulla The discussion covers midline suboccipital exposure, cerebellomedullary fissure dissection, opening of the tela choroidea and inferior medullary velum, and the principles of approaching intrinsic medullary and fourth ventricular lesions while preserving critical neurovascular structures. Telovelar & Far Lateral Approach The video integrates suboccipital craniectomy, cerebellomedullary fissure dissection, and anatomical corridors to safely access intrinsic medullary and fourth ventricular lesions. Emphasis is placed on surgical anatomy, approach selection, and operative strategy for brainstem pathology. Surgical Anatomy of the Pons & Safe Surgical Zones The discussion focuses on the key anatomical landmarks of the basilar sulcus, middle cerebellar peduncle, facial colliculus, and cranial nerve exit zones, which guide safe operative corridors to intrinsic pontine lesions. Surgical Anatomy of Midbrain & Safe Surgical Zones The video explains the principles behind safe entry zones of the midbrain, their relationship to critical neural pathways, and how these zones guide surgical approaches for brainstem tumors, cavernous malformations, and intrinsic midbrain lesions.